, (benzyloxy)-3-methyl-1-oxobutan-2-yl)carbamoyl)-2methylhydrazinecarbonyl

C. B. Anfinsen, Principles that Govern the Folding of Protein Chains, Science 181, vol.4096, pp.223-230, 1973.

G. N. Ramachandran, C. Ramakrishnan, and V. Sasisekharan, Stereochemistry of polypeptide chain configurations, In: Journal of Molecular Biology, vol.7, issue.1, pp.95-99, 1963.
DOI : 10.1016/s0022-2836(63)80023-6

L. Pauling and R. B. Corey, Two Rippled-Sheet Configurations of Polypeptide Chains, and a Note about the Pleated Sheets, Proceedings of the National Academy of Sciences, vol.39, pp.253-256, 1953.
DOI : 10.1073/pnas.39.4.253

URL : http://www.pnas.org/content/39/4/253.full.pdf

A. Faisal and . Syud, Influence of Strand Number on Antiparallel betaSheet Stability in Designed Three-and Four-stranded beta-Sheets, Journal of Molecular Biology, vol.326, issue.2, pp.553-568, 2003.

W. F. Degrado and J. D. Lear, Induction of peptide conformation at apolar water interfaces. 1. A study with model peptides of defined hydrophobic periodicity, Journal of the American Chemical Society, vol.107, pp.7684-7689, 1985.

M. Stefani and C. M. Dobson, Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution, Journal of Molecular Medicine, vol.81, pp.678-699, 2003.

Y. S. Eisele, Targeting protein aggregation for the treatment of degenerative diseases, Nature Reviews Drug Discovery, vol.14, issue.11, pp.759-780, 2015.

D. Eisenberg and M. Jucker, The Amyloid State of Proteins in Human Diseases, Cell, vol.148, pp.1188-1203, 2012.

J. D. Gillmore and P. N. Hawkins, Pathophysiology and treatment of systemic amyloidosis, Nat Rev Nephrol, vol.9, issue.10, pp.574-586, 2013.

A. Christopher, M. A. Ross, and . Poirier, Protein aggregation and neurodegenerative disease, p.1, 2004.

, , pp.10-17, 2004.

F. Chiti and C. M. Dobson, Protein Misfolding, Functional Amyloid, and Human Disease, Annual Review of Biochemistry, vol.75, issue.1, pp.333-366, 2006.

A. Aguzzi and T. Connor, Protein aggregation diseases: pathogenicity and therapeutic perspectives, Nature Reviews Drug Discovery, vol.9, issue.3, pp.237-248, 2010.

J. D. Sipe, Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis, Amyloid: The International Journal of Experimental and Clinical Investigation: The Official Journal of the International Society of Amyloidosis, vol.19, pp.167-170, 2012.

V. N. Uversky, Protein folding revisited. A polypeptide chain at the folding-misfolding-nonfolding cross-roads: which way to go?, In: Cellular and Molecular Life Sciences CMLS, vol.60, issue.9, pp.1852-1871, 2003.

G. Clarke, A one-hit model of cell death in inherited neuronal degenerations, Nature, vol.406, pp.195-199, 2000.

A. Singleton, A. Myers, and J. Hardy, The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases, Human Molecular Genetics, vol.13, issue.1, pp.123-126, 2004.

W. Colon and J. W. Kelly, Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro, Biochemistry 31, vol.36, pp.8654-8660, 1992.

H. , J. Dyson, and P. E. Wright, Intrinsically unstructured proteins and their functions, Nature Reviews Molecular Cell Biology, vol.6, issue.3, pp.197-208, 2005.

K. S. Kosik, C. L. Joachim, and D. J. Selkoe, Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease, Proceedings of the National Academy of Sciences, vol.83, pp.4044-4048, 1986.

H. Mihael and . Polymeropoulos, Mutation in the alpha-Synuclein Gene Identified in Families with Parkinson's Disease, Science 276, vol.5321, pp.2045-2047, 1997.

M. S. Wolfe, Tau Mutations in Neurodegenerative Diseases, Journal of Biological Chemistry, vol.284, pp.6021-6025, 2009.

T. R. Serio, Nucleated conformational conversion and the replication of conformational information by a prion determinant, Science, vol.289, pp.1317-1321, 2000.

A. R. Hurshman, Transthyretin aggregation under partially denaturing conditions is a downhill polymerization, Biochemistry 43, vol.23, pp.7365-7381, 2004.

B. B. Holmes, Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds, Proceedings of the National Academy of Sciences 110.33, pp.3138-3147, 2013.

M. , Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones, Human Molecular Genetics, vol.23, issue.1, pp.157-170, 2014.

K. Yanamandra, Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo, Neuron, vol.80, issue.2, pp.402-414, 2013.

P. Westermark, Aspects on human amyloid forms and their fibril polypeptides, FEBS Journal, vol.272, issue.23, pp.5942-5949, 2005.

B. Winner, In vivo demonstration that alpha-synuclein oligomers are toxic, Proceedings of the National Academy of Sciences, vol.108, pp.4194-4199, 2011.

K. Ono, M. M. Condron, and D. B. Teplow, Structure-neurotoxicity relationships of amyloid beta-protein oligomers, Proceedings of the National Academy of Sciences, vol.106, pp.14745-14750, 2009.

M. Goedert and M. G. Spillantini, A Century of Alzheimer's Disease, Science, vol.314, pp.777-781, 2006.

P. Mark and . Mattson, Pathways towards and away from Alzheimer's disease, pp.631-639, 2004.

P. T. Francis, The cholinergic hypothesis of Alzheimer's disease: a review of progress, Neurosurgery & Psychiatry, vol.66, issue.2, pp.137-147, 1999.

T. Scholz and E. Mandelkow, Transport and diffusion of Tau protein in neurons, Cellular and Molecular Life Sciences, vol.71, pp.3139-3150, 2014.

H. Zempel and E. Mandelkow, Lost after translation: missorting of Tau protein and consequences for Alzheimer disease, Trends in Neurosciences, vol.37, pp.721-732, 2014.

B. Eftekharzadeh, B. T. Hyman, and S. Wegmann, Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases, Mechanisms of Ageing and Development, vol.156, pp.1-13, 2016.

K. Iqbal and I. Grundke, Inhibition of Neurofibrillary Degeneration: A Promising Approach to Alzheimers Disease and Other Tauopathies, Current Drug Targets, vol.5, issue.6, pp.495-502, 2004.

B. Zhang, The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice, The Journal of Neuroscience, vol.32, pp.3601-3611, 2012.

E. Akoury, Mechanistic Basis of Phenothiazine-Driven Inhibition of Tau Aggregation, Angewandte Chemie International Edition, vol.52, pp.3511-3515, 2013.

A. Boutajangout, Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain, Journal of Neurochemistry, vol.118, pp.658-667, 2011.

R. N. Rosenberg, Metal Chelation Therapy for Alzheimer Disease, Archives of Neurology, vol.60, pp.1678-1679, 2003.

L. Muralidhar and . Hegde, Challenges Associated with Metal Chelation Therapy in Alzheimer's Disease, Journal of Alzheimer's Disease, vol.17, issue.3, pp.457-468, 2009.

M. F. Luiza and . Gomes, 8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Abeta peptide aggregation, Journal of Inorganic Biochemistry, vol.139, pp.106-116, 2014.

A. Kochi, A novel hybrid of 6-chlorotacrine and metal-amyloidbeta modulator for inhibition of acetylcholinesterase and metal-induced amyloid-beta aggregation, Chemical Science, vol.4, issue.11, pp.4137-4145, 2013.

H. A. Pearson and C. Peers, Physiological roles for amyloid beta peptides, The Journal of Physiology, vol.575, pp.5-10, 2006.

U. C. Müller and H. Zheng, Physiological Functions of APP Family Proteins, Cold Spring Harbor Perspectives in Medicine, vol.2, p.6288, 2012.

G. Thinakaran and E. H. Koo, Amyloid Precursor Protein Trafficking, Processing, and Function, Journal of Biological Chemistry, vol.283, pp.29615-29619, 2008.

A. Güntert, H. Döbeli, and B. Bohrmann, High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain, Neuroscience 143, vol.2, pp.461-475, 2006.

D. J. Selkoe, Alzheimer's Disease: Genes, Proteins, and Therapy, Physiological Reviews, vol.81, issue.2, pp.741-766, 2001.

E. Mcgowan, Abeta42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice, Neuron, vol.47, pp.191-199, 2005.

W. Kim and M. H. Hecht, Sequence Determinants of Enhanced Amyloidogenicity of Alzheimer Abeta42 Peptide Relative to Abeta40, Journal of Biological Chemistry, vol.280, pp.35069-35076, 2005.

T. Takahashi and H. Mihara, Peptide and Protein Mimetics Inhibiting Amyloid beta-Peptide Aggregation, Accounts of Chemical Research, vol.41, pp.1309-1318, 2008.

I. A. Samuel and . Cohen, Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism, Proceedings of the National Academy of Sciences 110.24, pp.9758-9763, 2013.

S. Matsumura, Two Distinct Amyloid beta-Protein (Abeta) Assembly Pathways Leading to Oligomers and Fibrils Identified by Combined Fluorescence Correlation Spectroscopy, Morphology, and Toxicity Analyses, Journal of Biological Chemistry, vol.286, pp.11555-11562, 2011.

J. Sun-jeong, Novel Mechanistic Insight into the Molecular Basis of Amyloid Polymorphism and Secondary Nucleation during Amyloid Formation, Journal of Molecular Biology, vol.425, pp.1765-1781, 2013.

T. Gurry and C. M. Stultz, Mechanism of Amyloid-beta Fibril Elongation, Biochemistry 53, vol.44, pp.6981-6991, 2014.

C. Louise and . Serpell, Alzheimer's amyloid fibrils: structure and assembly, Biochimica et Biophysica Acta, vol.1, pp.16-30, 2000.

R. Zhang, Interprotofilament interactions between Alzheimer's Abeta1-42 peptides in amyloid fibrils revealed by cryoEM, Proceedings of the National Academy of Sciences, vol.106, pp.4653-4658, 2009.

K. Rajasekhar, M. Chakrabarti, and T. Govindaraju, Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease, pp.13434-13450, 2015.

M. Fändrich, M. Schmidt, and N. Grigorieff, Recent progress in understanding Alzheimer's beta-amyloid structures, Trends in biochemical sciences, vol.36, issue.6, pp.338-345, 2011.

M. Schmidt, Comparison of Alzheimer Abeta(1-40) and Abeta(1-42) amyloid fibrils reveals similar protofilament structures, Proceedings of the National Academy of Sciences 106.47, pp.19813-19818, 2009.

R. Cukalevski, The Abeta40 and Abeta42 peptides selfassemble into separate homomolecular fibrils in binary mixtures but cross-react during primary nucleation, Chemical Science, vol.6, pp.4215-4233, 2015.

T. Lührs, 3D structure of Alzheimer's amyloid-beta(1-42) fibrils, Proceedings of the National Academy of Sciences of the United States of America, vol.102, pp.17342-17347, 2005.

W. M. Tay, The Alzheimer's Amyloid-beta(1-42) Peptide Forms Off-Pathway Oligomers and Fibrils That Are Distinguished Structurally by Intermolecular Organization, Journal of Molecular Biology, vol.425, pp.2494-2508, 2013.

M. Ahmed, Structural conversion of neurotoxic amyloidbeta(1-42) oligomers to fibrils, Nature structural & molecular biology, vol.17, issue.5, pp.561-567, 2010.

H. Verena and . Finder, The Recombinant Amyloid-beta Peptide Abeta1-42 Aggregates Faster and Is More Neurotoxic than Synthetic Abeta1-42, Journal of Molecular Biology, vol.396, issue.1, pp.9-18, 2010.

G. Meisl, Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Abeta40 and Abeta42 peptides, Proceedings of the National Academy of Sciences 111.26, pp.9384-9389, 2014.

L. Yu, Structural Characterization of a Soluble Amyloid beta-Peptide Oligomer, Biochemistry 48.9, pp.1870-1877, 2009.

A. Laganowsky, Atomic view of a toxic amyloid small oligomer, Science, vol.335, pp.1228-1231, 2012.

D. Huang, Antiparallel beta-Sheet Structure within the C-Terminal Region of 42-Residue Alzheimer's Amyloid-beta Peptides When They Form 150-kDa Oligomers, Journal of Molecular Biology, vol.427, pp.2319-2328, 2015.

D. , A. Butterfield, A. M. Swomley, and R. Sultana, Amyloid beta-Peptide (1-42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression, Antioxidants & Redox Signaling, vol.19, pp.823-835, 2012.

C. Haass and D. J. Selkoe, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid betapeptide, Nature Reviews Molecular Cell Biology, vol.8, issue.2, pp.101-112, 2007.

P. Cizas, Size-dependent neurotoxicity of beta-amyloid oligomers, Archives of Biochemistry and Biophysics, vol.496, issue.2, pp.84-92, 2010.

P. Prangkio, Multivariate Analyses of Amyloid-Beta Oligomer Populations Indicate a Connection between Pore Formation and Cytotoxicity, PLOS ONE, vol.7, issue.10, p.47261, 2012.

M. Ganesh and . Shankar, Amyloid beta-Protein Dimers Isolated Directly from Alzheimer Brains Impair Synaptic Plasticity and Memory". In: Nature medicine 14, vol.8, pp.837-842, 2008.

K. N. Dahlgren, Oligomeric and Fibrillar Species of Amyloidbeta Peptides Differentially Affect Neuronal Viability, Journal of Biological Chemistry, vol.277, pp.32046-32053, 2002.

F. Tofoleanu and N. Buchete, Alzheimer Abeta peptide interactions with lipid membranes, Prion 6, vol.4, pp.339-345, 2012.

J. Wang, New Insights in Amyloid Beta Interactions with Human Telomerase, Journal of the American Chemical Society, vol.137, issue.3, pp.1213-1219, 2015.

C. Shi, Intromitochondrial IB/NF-B signaling pathway is involved in amyloid beta peptide-induced mitochondrial dysfunction, Journal of Bioenergetics and Biomembranes, vol.46, pp.371-376, 2014.

A. Reza and A. Ladiwala, Conformational Differences between Two Amyloid beta Oligomers of Similar Size and Dissimilar Toxicity, Journal of Biological Chemistry, vol.287, pp.24765-24773, 2012.

K. L. Viola and W. L. Klein, Amyloid beta oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis, Acta Neuropathologica, vol.129, issue.2, pp.183-206, 2015.

G. Fernanda and . De-felice, Protection of synapses against Alzheimer'slinked toxins: Insulin signaling prevents the pathogenic binding of Abeta oligomers, Proceedings of the National Academy of Sciences, vol.106, pp.1971-1976, 2009.

G. Dimitra and . Georganopoulou, Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease, Proceedings of the National Academy of Sciences of the United States of America, vol.102, pp.2273-2276, 2005.

K. Gunnar and . Gouras, Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease, Acta Neuropathologica, vol.119, issue.5, pp.523-541, 2010.

V. Schmidt, A. Carlo, and T. E. Willnow, Apolipoprotein E receptor pathways in Alzheimer disease, Wiley Interdisciplinary Reviews, vol.6, pp.255-270, 2014.
DOI : 10.1002/wsbm.1262

S. Cattepoel, Chronic Intranasal Treatment with an AntiAbeta 30-42 scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease, PLOS ONE, vol.6, p.18296, 2011.

A. Takamura, Sortilin is required for toxic action of Abeta oligomers (AbetaOs): Extracellular AbetaOs trigger apoptosis, and intraneuronal AbetaOs impair degradation pathways". In: Life Sciences. Contribution of Intraneuronal Amyloid beta Accumulation to Alzheimer's Disease 91, pp.1177-1186, 2012.

M. P. Lambert, Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies, Journal of Neurochemistry, vol.79, pp.595-605, 2001.

G. Fernanda and . De-felice, Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Abeta oligomers, Neurobiology of Aging, vol.29, pp.1334-1347, 2008.

P. N. Lacor, Synaptic Targeting by Alzheimer's-Related Amyloid beta Oligomers, The Journal of Neuroscience, vol.24, pp.10191-10200, 2004.
DOI : 10.1523/jneurosci.3432-04.2004

URL : http://www.jneurosci.org/content/24/45/10191.full.pdf

M. P. Lambert, Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins, Proceedings of the National Academy of Sciences, vol.95, pp.6448-6453, 1998.
DOI : 10.1073/pnas.95.11.6448

URL : http://www.pnas.org/content/95/11/6448.full.pdf

N. Arispe, Architecture of the Alzheimer's AbetaP Ion Channel Pore, The Journal of Membrane Biology, vol.197, issue.1, pp.33-48, 2004.

. Kelly-willemijn-menting, A. H. Jurgen, and . Claassen, betasecretase inhibitor; a promising novel therapeutic drug in Alzheimer's disease, Frontiers in Aging Neuroscience, vol.6, p.165, 2014.

K. Arun, H. L. Ghosh, and . Osswald, BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer's disease, Chemical Society Reviews, vol.43, pp.6765-6813, 2014.

N. Edraki, N-(2-(Piperazin-1-yl)phenyl)arylamide Derivatives as beta-Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four-Component Reaction and Biological Evaluation, Archiv Der Pharmazie, vol.348, pp.330-337, 2015.

K. W. Hunt, Spirocyclic beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid beta in a Higher Species, Journal of Medicinal Chemistry, vol.56, pp.3379-3403, 2013.

A. A. Thomas, Discovery of 7-Tetrahydropyran-2-yl Chromans: beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors That Reduce Amyloid beta-Protein (Abeta) in the Central Nervous System, Journal of Medicinal Chemistry, vol.57, issue.3, pp.878-902, 2014.

H. Hilpert, beta-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease, Journal of Medicinal Chemistry, vol.56, pp.3980-3995, 2013.

J. Chen, Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious beta-secretase inhibitors for the potential treatment of Alzheimer's disease, Bioorganic & Medicinal Chemistry Letters, vol.25, pp.767-774, 2015.

N. Razzaghi-asl, Design and synthesis of novel 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridines as small molecule BACE-1 inhibitors, Bioorganic & Medicinal Chemistry, vol.21, pp.6893-6909, 2013.

J. Hu, The Resveratrol Trimer Miyabenol C Inhibits betaSecretase Activity and beta-Amyloid Generation, PLOS ONE, vol.10, p.115973, 2015.

B. Cheng, Inhibiting toxic aggregation of amyloidogenic proteins: A therapeutic strategy for protein misfolding diseases, Biochimica et Biophysica Acta, pp.4860-4871, 2013.

M. Pettersson, Discovery of indole-derived pyridopyrazine1,6-dione-secretase modulators that target presenilin, Bioorganic & Medicinal Chemistry Letters, vol.25, pp.908-913, 2015.

A. I. Velter, Anilinotriazoles as potent gamma secretase modulators, Bioorganic & Medicinal Chemistry Letters, vol.24, pp.5805-5813, 2014.

D. Schenk, Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse, Nature, vol.400, pp.173-177, 1999.

F. Bard, Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease, Nature Medicine, vol.6, pp.916-919, 2000.

J. Orgogozo, Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization, Neurology, vol.61, issue.1, pp.46-54, 2003.

G. Krafft, ACU-193: A candidate therapeutic antibody that selectively targets soluble beta-amyloid oligomers, Alzheimer's & Dementia: The Journal of the Alzheimer's Association, vol.9, p.326, 2013.

L. Pradier, SAR228810: An antiprotofibrillar beta-amyloid antibody designed to reduce risk of amyloid-related imaging abnormalities (ARIA), Alzheimer's & Dementia: The Journal of the Alzheimer's Association, vol.9, pp.808-809, 2013.

P. E. Cramer, ApoE-Directed Therapeutics Rapidly Clear beta-Amyloid and Reverse Deficits in AD Mouse Models, Science, vol.335, pp.1503-1506, 2012.

R. Deane, Z. Wu, and B. V. Zlokovic, RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier, Stroke

, Journal of Cerebral Circulation, vol.35, pp.2628-2631, 2004.

A. Robert, D. M. Marr, and . Hafez, Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance, Frontiers in Aging Neuroscience, vol.6, p.187, 2014.

A. Fleming, Chemical modulators of autophagy as biological probes and potential therapeutics, Nature Chemical Biology, vol.7, issue.1, pp.9-17, 2011.

I. Santa-maria, Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau, Molecular Neurodegeneration, vol.2, p.17, 2007.

L. Zhang, Processing of Alzheimer's Amyloid Precursor Protein during H2O2-Induced Apoptosis in Human Neuronal Cells, Biochemical and Biophysical Research Communications, vol.235, issue.3, pp.845-848, 1997.

H. Xie, Catechins and Procyanidins of Ginkgo biloba Show Potent Activities towards the Inhibition of beta-Amyloid Peptide Aggregation and Destabilization of Preformed Fibrils, Molecules, vol.19, pp.5119-5134, 2014.

J. Bieschke, EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity, Proceedings of the National Academy of Sciences 107.17, pp.7710-7715, 2010.

M. Ganguli, Ten-year incidence of dementia in a rural elderly US community population The MoVIES Project, Neurology, vol.54, pp.1109-1116, 2000.

D. Yanagisawa, Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP/PS1 mice, Neurobiology of Aging, vol.36, issue.1, pp.201-210, 2015.

K. Ono, Effects of Grape Seed-derived Polyphenols on Amyloid beta-Protein Self-assembly and Cytotoxicity, Journal of Biological Chemistry, vol.283, pp.32176-32187, 2008.

S. Rigacci, Aβ(1-42) Aggregates into Non-Toxic Amyloid Assemblies in the Presence of the Natural Polyphenol Oleuropein Aglycon, Current Alzheimer Research, vol.8, pp.841-852, 2011.

S. Sinha, Lysine-Specific Molecular Tweezers Are Broad-Spectrum Inhibitors of Assembly and Toxicity of Amyloid Proteins, Journal of the American Chemical Society, vol.133, pp.16958-16969, 2011.

Y. Nakagami, A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of longterm potentiation in vitro, British Journal of Pharmacology, vol.137, pp.676-682, 2002.

T. Arai, Rational design and identification of a nonpeptidic aggregation inhibitor of amyloid-beta based on a pharmacophore motif obtained from cyclo, International Ed. in English), vol.53, pp.8236-8239, 2014.

C. Soto, Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy, Nature Medicine, vol.4, issue.7, pp.822-826, 1998.

L. O. Tjernberg, Arrest of-Amyloid Fibril Formation by a Pentapeptide Ligand, Journal of Biological Chemistry, vol.271, pp.8545-8548, 1996.

C. Adessi, Pharmacological Profiles of Peptide Drug Candidates for the Treatment of Alzheimer's Disease, Journal of Biological Chemistry, vol.278, pp.13905-13911, 2003.

C. Giordano, Synthesis and activity of fibrillogenesis peptide inhibitors related to the 17-21 beta-amyloid sequence, European Journal of Medicinal Chemistry, vol.44, issue.1, pp.179-189, 2009.

A. Mark and . Findeis, Modified-Peptide Inhibitors of Amyloid beta-Peptide Polymerization, Biochemistry 38, vol.21, pp.6791-6800, 1999.

S. Akikusa, Practical assay and molecular mechanism of aggregation inhibitors of beta-amyloid, The Journal of Peptide Research: Official Journal of the American Peptide Society, vol.61, issue.1, pp.1-6, 2003.

N. Acerra, N. M. Kad, and J. M. Mason, Combining intracellular selection with protein-fragment complementation to derive Abeta interacting peptides, Protein Engineering Design and Selection, vol.26, pp.463-470, 2013.

A. Paul, Inhibition of Alzheimer's amyloid-beta peptide aggregation and its disruption by a conformationally restricted alpha/beta hybrid peptide, Chemical Communications, vol.51, pp.2245-2248, 2015.

L. Tao and . Lowe, Structure?Function Relationships for Inhibitors of beta-Amyloid Toxicity Containing the Recognition Sequence KLVFF, Biochemistry 40, vol.26, pp.7882-7889, 2001.

C. W. Cairo, Affinity-Based Inhibition of beta-Amyloid Toxicity, Biochemistry 41, vol.27, pp.8620-8629, 2002.

L. Fülöp, beta-Amyloid-derived pentapeptide RIIGLa inhibits Abeta1-42 aggregation and toxicity, Biochemical and Biophysical Research Communications, vol.324, pp.64-69, 2004.

M. A. Etienne, Stoichiometric Inhibition of Amyloid beta-Protein Aggregation with Peptides Containing Alternating alpha,alpha-Disubstituted Amino Acids, Journal of the American Chemical Society, vol.128, pp.3522-3523, 2006.
DOI : 10.1021/ja0600678

M. Taylor, Development of a Proteolytically Stable RetroInverso Peptide Inhibitor of beta-Amyloid Oligomerization as a Potential Novel Treatment for Alzheimer's Disease, Biochemistry 49, vol.15, pp.3261-3272, 2010.

P. Rzepecki and T. Schrader, beta-Sheet Ligands in Action: KLVFF Recognition by Aminopyrazole Hybrid Receptors in Water, Journal of the American Chemical Society, vol.127, issue.9, pp.3016-3025, 2005.

Y. Zhou, Structural Optimization and Biological Evaluation of Substituted Bisphenol A Derivatives as beta-Amyloid Peptide Aggregation Inhibitors, Journal of Medicinal Chemistry, vol.53, pp.5449-5466, 2010.

K. Chaitanya-nadimpally, A. Paul, and B. Mandal, Reversal of Aggregation Using beta-Breaker Dipeptide Containing Peptides: Application to Abeta(1-40) Self-Assembly and Its Inhibition, ACS Chemical Neuroscience, vol.5, pp.400-408, 2014.

J. Kumar, R. Namsechi, and V. L. Sim, Structure-Based Peptide Design to Modulate Amyloid Beta Aggregation and Reduce Cytotoxicity, PLOS ONE, vol.10, p.129087, 2015.

J. A. Loureiro, Fluorinated beta-sheet breaker peptides, Journal of Materials Chemistry B, vol.2, pp.2259-2264, 2014.

J. Kaffy, Designed Glycopeptidomimetics Disrupt Protein-Protein Interactions Mediating Amyloid beta-Peptide Aggregation and Restore Neuroblastoma Cell Viability, Journal of Medicinal Chemistry, vol.59, pp.2025-2040, 2016.

J. Kaffy, Structure-activity relationships of sugar-based peptidomimetics as modulators of amyloid beta-peptide early oligomerization and fibrillization, European Journal of Medicinal Chemistry, vol.86, pp.752-758, 2014.

K. Rajasekhar, Rationally Designed Peptidomimetic Modulators of Abeta Toxicity in Alzheimer's Disease", In: Scientific Reports, vol.5, p.8139, 2015.

Y. Kallberg, Prediction of Amyloid Fibril-forming Proteins, Journal of Biological Chemistry, vol.276, pp.12945-12950, 2001.

K. Matsuzaki, Design, synthesis, and biophysical properties of a helical Abeta1-42 analog: Inhibition of fibrillogenesis and cytotoxicity, Biochemical and Biophysical Research Communications, vol.371, pp.777-780, 2008.

E. Brandenburg, Inhibition of Amyloid Aggregation by Formation of Helical Assemblies, Chemistry-A European Journal, vol.17, pp.10651-10661, 2011.

C. Nerelius, alpha-Helix targeting reduces amyloid-beta peptide toxicity, Proceedings of the National Academy of Sciences, vol.106, pp.9191-9196, 2009.

M. Ito, Effects of Ligands on Unfolding of the Amyloid betaPeptide Central Helix: Mechanistic Insights from Molecular Dynamics Simulations, PLOS ONE, vol.7, p.30510, 2012.

D. Honcharenko, Synthesis and evaluation of antineurotoxicity properties of an amyloid-beta peptide targeting ligand containing a triamino acid, Organic & Biomolecular Chemistry, vol.12, pp.6684-6693, 2014.

G. Guichard and I. Huc, Synthetic foldamers, Chemical Communications, vol.47, pp.5933-5941, 2011.

L. Vahdati, Synthesis and conformational studies of a stable peptidomimetic beta-hairpin based on a bifunctional diketopiperazine turn inducer, New Journal of Chemistry, vol.39, pp.3250-3258, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01366397

L. Fülöp, A Foldamer-Dendrimer Conjugate Neutralizes Synaptotoxic beta-Amyloid Oligomers, PLOS ONE, vol.7, p.39485, 2012.

J. and P. Turner, Rationally Designed Peptoids Modulate Aggregation of Amyloid-Beta 40, ACS Chemical Neuroscience, vol.5, pp.552-558, 2014.

Y. Luo, Abeta42-Binding Peptoids as Amyloid Aggregation Inhibitors and Detection Ligands, ACS Chemical Neuroscience, vol.4, issue.6, pp.952-962, 2013.

G. Yamin, P. Ruchala, and D. B. Teplow, A Peptide Hairpin Inhibitor of Amyloid beta-Protein Oligomerization and Fibrillogenesis, Biochemistry 48, vol.48, pp.11329-11331, 2009.

N. L. Kelly and . Huggins, Designed Hairpin Peptides Interfere with Amyloidogenesis Pathways: Fibril Formation and Cytotoxicity Inhibition, Interception of the Preamyloid State, Biochemistry 50, vol.38, pp.8202-8212, 2011.

G. Hopping, Designed Trpzip-3 beta-Hairpin Inhibits Amyloid Formation in Two Different Amyloid Systems, ACS Medicinal Chemistry Letters, vol.4, issue.9, pp.824-828, 2013.

J. S. Nowick, E. M. Smith, and G. Noronha, Molecular Scaffolds. 3. An Artificial Parallel .beta.-Sheet, The Journal of Organic Chemistry, vol.60, issue.23, pp.7386-7387, 1995.

J. S. Nowick, An Artificial beta-Sheet Comprising a Molecular Scaffold, a beta-Strand Mimic, and a Peptide Strand1, Journal of the American Chemical Society, vol.118, pp.2764-2765, 1996.

R. and J. Woods, Cyclic Modular beta-Sheets, Journal of the American Chemical Society, vol.129, issue.9, pp.2548-2558, 2007.

P. Cheng, Amyloid beta-sheet mimics that antagonize protein aggregation and reduce amyloid toxicity, Nature Chemistry, vol.4, issue.11, pp.927-933, 2012.

J. Zheng, Macrocyclic beta-Sheet Peptides That Inhibit the Aggregation of a Tau-Protein-Derived Hexapeptide, Journal of the American Chemical Society, vol.133, issue.9, pp.3144-3157, 2011.

C. Liu, Characteristics of Amyloid-Related Oligomers Revealed by Crystal Structures of Macrocyclic beta-Sheet Mimics, Journal of the American Chemical Society, vol.133, pp.6736-6744, 2011.

J. Luo, Inhibiting and Reversing Amyloid-beta Peptide (1-40) Fibril Formation with GramicidinS and Engineered Analogues, Chemistry-A European Journal, vol.19, pp.17338-17348, 2013.

Y. Xiao, Abeta(1-42) Fibril Structure Illuminates Selfrecognition and Replication of Amyloid in Alzheimer's, Nature structural & molecular biology, vol.22, issue.6, pp.499-505, 2015.

B. Dorgeret, Sugar-based peptidomimetics inhibit amyloid beta-peptide aggregation, European Journal of Medicinal Chemistry, vol.46, pp.5959-5969, 2011.

M. Bartolini and V. Andrisano, Strategies for the Inhibition of Protein Aggregation in Human Diseases, ChemBioChem 11, vol.8, pp.1018-1035, 2010.

C. I. Stains, K. Mondal, and I. Ghosh, Molecules that Target beta-Amyloid, pp.1674-1692, 2007.

S. Pellegrino, Asymmetric Modular Synthesis of a Semirigid Dipeptide Mimetic by Cascade Cycloaddition/Ring Rearrangement and Borohydride Reduction, The Journal of Organic Chemistry, vol.79, pp.3094-3102, 2014.

M. Landau, Towards a Pharmacophore for Amyloid, PLOS Biol, vol.9, issue.6, p.1001080, 2011.

A. Contini and E. Erba, Click-chemistry approach to azacycloalkene monosulfonyl diamines: synthesis and computational analysis of the reaction mechanism, pp.10652-10660, 2012.

B. Eckhardt, Structural characterization of a beta-turn mimic within a protein-protein interface, Proceedings of the National Academy of Sciences, vol.107, pp.18336-18341, 2010.

S. Pellegrino, Expedient chemical synthesis of 75mer DNA binding domain of MafA: an insight on its binding to insulin enhancer, Amino Acids, vol.43, pp.1995-2003, 2012.

D. S. King, C. G. Fields, and G. B. Fields, A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis, International Journal of Peptide and Protein Research, vol.36, issue.3, pp.255-266, 1990.

N. J. Greenfield, Using circular dichroism spectra to estimate protein secondary structure, Nature protocols, vol.1, issue.6, pp.2876-2890, 2006.

L. J. Smith, Analysis of main chain torsion angles in proteins: prediction of NMR coupling constants for native and random coil conformations, Journal of Molecular Biology, vol.255, issue.3, pp.494-506, 1996.

D. S. Wishart, 1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects, Journal of biomolecular NMR, vol.5, issue.1, pp.67-81, 1995.

C. D. Tatko, L. Marcey, and . Waters, Selective Aromatic Interactions in beta-Hairpin Peptides, Journal of the American Chemical Society, vol.124, pp.9372-9373, 2002.

L. Rosa, Design, structural and biological characterization of a VEGF inhibitor beta-hairpin-constrained peptide, European Journal of Medicinal Chemistry, vol.73, pp.210-216, 2014.

P. Cuniasse, Accounting for Conformational Variability in NMR Structure of Cyclopeptides: Ensemble Averaging of Interproton Distance and Coupling Constant Restraints, Journal of the American Chemical Society, vol.119, pp.5239-5248, 1997.

A. M. Fernández-escamilla, Design and NMR conformational study of a beta-sheet peptide based on Betanova and WW domains, Protein Science : A Publication of the Protein Society, vol.15, pp.2278-2289, 2006.

M. Biancalana and S. Koide, Molecular mechanism of Thioflavin-T binding to amyloid fibrils, Biochimica Et Biophysica Acta, vol.1804, issue.7, pp.1405-1412, 2010.

A. I. Sulatskaya, I. M. Kuznetsova, and K. K. Turoverov, Interaction of Thioflavin T with Amyloid Fibrils: Fluorescence Quantum Yield of Bound Dye, The Journal of Physical Chemistry B, vol.116, pp.2538-2544, 2012.

C. Rodríguez-rodríguez, Crystal structure of thioflavin-T and its binding to amyloid fibrils: insights at the molecular level, Chemical Communications, vol.46, pp.1156-1158, 2010.

N. Kokkoni, N-Methylated Peptide Inhibitors of betaAmyloid Aggregation and Toxicity. Optimization of the Inhibitor Structure, Biochemistry 45, vol.32, pp.9906-9918, 2006.

M. Sidhartha and . Chafekar, Branched KLVFF Tetramers Strongly Potentiate Inhibition of beta-Amyloid Aggregation, ChemBioChem 8.15, pp.1857-1864, 2007.

D. Brinet, An improved capillary electrophoresis method for in vitro monitoring of the challenging early steps of Abeta1-42 peptide oligomerization: Application to anti-Alzheimer's drug discovery, ELECTROPHORESIS, vol.35, pp.3302-3309, 2014.

Y. Feng, Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation, Neurotoxicology, vol.30, issue.6, pp.986-995, 2009.

S. Sinha, Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the Polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01, ACS Chemical Neuroscience, vol.3, issue.6, pp.451-458, 2012.

S. Hyung, Insights into antiamyloidogenic properties of the green tea extract (?)-epigallocatechin-3-gallate toward metalassociated amyloid-beta species, Proceedings of the National Academy of Sciences, vol.110, pp.3743-3748, 2013.

J. Bieschke, Small-molecule conversion of toxic oligomers to nontoxic beta-sheet-rich amyloid fibrils, Nature Chemical Biology, vol.8, issue.1, pp.93-101, 2012.

J. S. Nowick, An Unnatural Amino Acid that Mimics a Tripeptide beta-Strand and Forms beta-Sheetlike Hydrogen-Bonded Dimers, Journal of the American Chemical Society, vol.122, pp.7654-7661, 2000.

L. Bannwarth, Molecular Tongs Containing Amino Acid Mimetic Fragments: New Inhibitors of Wild-Type and Mutated HIV-1

, Protease Dimerization". In: Journal of Medicinal Chemistry, vol.49, pp.4657-4664, 2006.

A. Vidu, Toward the First Nonpeptidic Molecular Tong Inhibitor of Wild-Type and Mutated HIV-1 Protease Dimerization, ChemMedChem 5, vol.11, pp.1899-1906, 2010.

F. Tamaddon, A. Nasiri, and S. Farokhi, CsF-Celite as an efficient heterogeneous catalyst for sulfonylation and desulfonylation of heteroatoms, Catalysis Communications, vol.12, pp.1477-1482, 2011.

S. Joginder and . Bajwa, Deprotection of N-tosylated indoles and related structures using cesium carbonate, Tetrahedron Letters, vol.47, pp.6425-6427, 2006.

T. Katagiri, Preparation of Optically Pure alphaTrifluoromethyl-alpha-amino Acids from N-Tosyl-2-trifluoromethyl-2-alkyloxycarbonyl Aziridine, The Journal of Organic Chemistry, vol.76, pp.9305-9311, 2011.

V. Lupi, Synthesis of 2,6-disubstituted morpholines through regioselective oxiranes ring opening by tosylamide under PTC conditions, Tetrahedron, vol.60, pp.11709-11718, 2004.

T. Fukuyama, C. Jow, and M. Cheung, 2-and 4-Nitrobenzenesulfonamides: Exceptionally versatile means for preparation of secondary amines and protection of amines, Tetrahedron Letters, vol.36, pp.6373-6374, 1995.

P. E. Maligres, Nosylaziridines: Activated aziridine electrophiles, Tetrahedron Letters, vol.38, pp.5253-5256, 1997.

P. Wipf and T. C. Henninger, Solid-Phase Synthesis of Peptide Mimetics with (E)-Alkene Amide Bond Replacements Derived from Alkenylaziridines, The Journal of Organic Chemistry, vol.62, issue.6, pp.1586-1587, 1997.

C. Stephen, T. S. Miller, and . Scanlan, Site-Selective N-Methylation of Peptides on Solid Support, Journal of the American Chemical Society, vol.119, issue.9, pp.2301-2302, 1997.

H. An and P. Cook, Solution phase combinatorial chemistry I. synthesis of polyazacyclophane scaffolds and tertiary amine libraries, Tetrahedron Letters, vol.37, pp.7233-7236, 1996.

U. Bhatt, Derivatized oxopiperazine rings from amino acids, Tetrahedron Letters, vol.38, pp.3679-3682, 1997.

H. An, Synthesis of Novel Linear Pyridinopolyamine Libraries with Potent Antibacterial Activity, The Journal of Organic Chemistry, vol.62, pp.5156-5164, 1997.

T. Ibuka, A Thermodynamic Preference of Chiral NMethanesulfonyl and N-Arenesulfonyl 2,3-cis-3-Alkyl-2-Vinylaziridines over Their 2,3-Trans-Isomers: Useful Palladium(0)-Catalyzed Equilibration Reactions for the Synthesis of (E)-Alkene Dipeptide Isosteres, The Journal of Organic Chemistry, vol.62, pp.999-1015, 1997.

C. Philippe, Synthesis and evaluation of fluorinated analogues of monoamine reuptake inhibitors, Journal of Fluorine Chemistry. Special Issue: Fluorine Chemistry in France, vol.134, pp.136-145, 2012.

A. S. Kende, K. Liu, and K. M. Brands, Total Synthesis of (-)-Altemicidin: A Novel Exploitation of the Potier-Polonovski Rearrangement, Journal of the American Chemical Society, vol.117, pp.10597-10598, 1995.

K. Müller, C. Faeh, and F. Diederich, Fluorine in Pharmaceuticals: Looking Beyond Intuition, Science, vol.317, pp.1881-1886, 2007.

A. Bondi, van der Waals Volumes and Radii, The Journal of Physical Chemistry, vol.68, issue.3, pp.441-451, 1964.

E. Schweizer, A fluorine scan at the catalytic center of thrombin: C-F, C-OH, and C-OMe bioisosterism and fluorine effects on pKa and log D values, ChemMedChem, vol.1, issue.6, pp.611-621, 2006.

K. Zhao, Inhibition of dipeptidyl peptidase IV (DPP IV) by 2(2-amino-1-fluoro-propylidene)-cyclopentanecarbonitrile, a fluoroolefin containing peptidomimetic, Bioorganic & Medicinal Chemistry, vol.11, issue.2, pp.207-215, 2003.

E. Attila, . Pavlath-milo?, and . Hudlický, Chemistry of organic fluorine compounds II: a critical review, 1296.

R. Paulini, K. Müller, and F. Diederich, Orthogonal multipolar interactions in structural chemistry and biology, Angewandte Chemie, vol.12, pp.1788-1805, 2005.

K. L. Kirk, Selective fluorination in drug design and development: an overview of biochemical rationales, Current Topics in Medicinal Chemistry, vol.6, pp.1447-1456, 2006.

J. S. Nowick, An Extended beta-Strand Mimic for a Larger Artificial beta-Sheet, Journal of the American Chemical Society, vol.119, issue.23, pp.5413-5424, 1997.

J. H. Tsai, A. S. Waldman, and J. S. Nowick, Two New beta-strand Mimics, Bioorganic & Medicinal Chemistry, vol.7, issue.1, pp.29-38, 1999.

S. Kumar-mishra and N. Suryaprakash, Intramolecular hydrogen bonds involving organic fluorine in the derivatives of hydrazides: an NMR investigation substantiated by DFT based theoretical calculations, Physical chemistry chemical physics: PCCP, vol.17, pp.15226-15235, 2015.

M. L. Gelmi, 3-demethoxy-3-glycosylaminothiocolchicines: Synthesis of a new class of putative muscle relaxant compounds, Journal of Medicinal Chemistry, vol.49, pp.5571-5577, 2006.

R. Fanelli, Introduction of polar groups on the naphthalene scaffold of molecular tongs inhibiting wild-type and mutated HIV-1 protease dimerization, MedChemComm 5, vol.6, pp.719-727, 2014.

S. Messaoudi, J. Brion, and M. Alami, An Expeditious Copper-Catalyzed Access to 3-Aminoquinolinones, 3-Aminocoumarins and Anilines using Sodium Azide, Advanced Synthesis & Catalysis, vol.352, pp.1677-1687, 2010.

R. Abdol, F. Hajipour, and . Mohammadsaleh, Synthesis of aryl azides from aryl halides promoted by Cu2O/tetraethylammonium prolinate, Tetrahedron Letters, vol.50, pp.6799-6802, 2014.

J. T. Markiewicz, O. Wiest, and P. Helquist, Synthesis of primary aryl amines through a copper-assisted aromatic substitution reaction with sodium azide, The Journal of Organic Chemistry, vol.75, pp.4887-4890, 2010.

S. Voth, J. W. Hollett, and J. Adam-mccubbin, Transitionmetal-free access to primary anilines from boronic acids and a common (+)NH2 equivalent, The Journal of Organic Chemistry, vol.80, pp.2545-2553, 2015.

K. Miyashita, T. Sakai, and T. Imanishi, Total synthesis of (+/-)-spiroxin C, Organic Letters, vol.5, pp.2683-2686, 2003.

F. D. Bellamy and K. Ou, Selective reduction of aromatic nitro compounds with stannous chloride in non acidic and non aqueous medium, Tetrahedron Letters, vol.25, pp.839-842, 1984.

C. Adessi and C. Soto, Converting a Peptide into a Drug: Strategies to Improve Stability and Bioavailability, Current Medicinal Chemistry, vol.9, issue.9, pp.963-978, 2002.
DOI : 10.2174/0929867024606731

. Senthil-kumar-ramanathan, Modular Synthesis of Cyclic Peptidomimetics Inspired by-Turns, Organic Letters, vol.7, issue.6, pp.1059-1062, 2005.

H. Han and K. D. Janda, Azatides: Solution and Liquid Phase Syntheses of a New Peptidomimetic, Journal of the American Chemical Society, vol.118, issue.11, pp.2539-2544, 1996.

M. Thormann and H. Hofmann, Conformational properties of azapeptides, Journal of Molecular Structure: THEOCHEM, vol.469, issue.1, pp.63-76, 1999.
DOI : 10.1016/s0166-1280(98)00567-3

N. S. Freeman, M. Hurevich, and C. Gilon, Synthesis of N-substituted Ddz-protected hydrazines and their application in solid phase synthesis of aza-peptides, Tetrahedron, vol.65, pp.1737-1745, 2009.

R. E. Melendez and W. D. Lubell, Aza-Amino Acid Scan for Rapid Identification of Secondary Structure Based on the Application of N-Boc-Aza1-Dipeptides in Peptide Synthesis, Journal of the American Chemical Society, vol.126, pp.6759-6764, 2004.

W. Zhang, Impact of Azaproline on Amide Cis?Trans Isomerism: Conformational Analyses and NMR Studies of Model Peptides Including TRH Analogues, Journal of the American Chemical Society, vol.125, pp.1221-1235, 2003.

. Hans-jurgen, W. T. Hess, G. D. Moreland, and . Laubach, N[2-Isopropyl-3-(L-aspartyl-L-arginyl)-carbazoyl]-L-tyrosyl-L-valyl-Lhistidyl-L-prolyl-L-phenylalanine,1 an Isostere of Bovine Angiotensin II, Journal of the American Chemical Society, vol.85, pp.4040-4041, 1963.

H. Niedrich, Hydrazinverbindungen als Heterobestandteile in Peptiden. XVI. Synthese von 9-Hydrazinoessigsäure-, 9-Azaglycinund 5-alpha-Azaasparagin-Oxytocin, vol.314, pp.769-779, 1972.
DOI : 10.1002/prac.19743160504

P. Oehme, Pharmacology of hydrazino carbonic acids, hydrazino peptides and other hydrazine derivatives. IX. Studies on correlations between biological effect and structure of heterologeous eledoisinpenta, hexa and octapeptide sequences, Acta Biologica Et Medica Germanica, vol.28, pp.121-131, 1972.

H. Han, J. Yoon, and K. Janda, Investigations of azapeptides as mimetics of Leu-enkephalin, Bioorganic & Medicinal Chemistry Letters, vol.8, issue.1, pp.117-120, 1998.

S. Anand and . Dutta, Synthesis and biological activity of highly active .alpha.-aza analogs of luliberin, Journal of Medicinal Chemistry, vol.21, pp.1018-1024, 1978.

J. M. Gassman and J. Magrath, An active-site titrant for chymotrypsin, and evidence that azapeptide esters are less susceptible to nucleophilic attack than ordinary esters, Bioorganic & Medicinal Chemistry Letters, vol.6, pp.1771-1774, 1996.

J. E. Semple, Synthesis and biological activity of P2-P4 azapeptidomimetic P1-argininal and P1-ketoargininamide derivatives: a novel class of serine protease inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.7, issue.3, pp.315-320, 1997.

R. Xing and R. P. Hanzlik, Azapeptides as Inhibitors and Active Site Titrants for Cysteine Proteinases, Journal of Medicinal Chemistry, vol.41, pp.1344-1351, 1998.

T. L. Graybill, Synthesis and evaluation of azapeptide-derived inhibitors of serine and cysteine proteases, Bioorganic & Medicinal Chemistry Letters, vol.2, issue.11, pp.1375-1380, 1992.

T. L. Graybill, Synthesis and evaluation of diacylhydrazines as inhibitors of the interleukin-1beta converting enzyme (ICE), In: Bioorganic & Medicinal Chemistry Letters, vol.5, pp.1197-1202, 1995.

J. Magrath and R. H. Abeles, Cysteine protease inhibition by azapeptide esters, Journal of Medicinal Chemistry, vol.35, issue.23, pp.4279-4283, 1992.

E. Nader and . Abo-dya, Benzotriazole-Mediated Synthesis of Azapeptides: En Route to an Aza-Leuenkephalin Analogue, The Journal of Organic Chemistry, vol.78, pp.3541-3552, 2013.

D. Sabatino, Structure-Activity Relationships of GHRP, issue.6

, Azapeptide Ligands of the CD36 Scavenger Receptor by Solid-Phase Submonomer Azapeptide Synthesis, Journal of the American Chemical Society, vol.133, pp.12493-12506, 2011.

C. Proulx and W. D. Lubell, Copper-Catalyzed N-Arylation of Semicarbazones for the Synthesis of Aza-Arylglycine-Containing Aza-Peptides, Organic Letters, vol.12, pp.2916-2919, 2010.

C. B. Bourguet, Targeting the Prostaglandin F2alpha Receptor for Preventing Preterm Labor with Azapeptide Tocolytics, Journal of Medicinal Chemistry, vol.54, pp.6085-6097, 2011.

E. Wieczerzak, Novel azapeptide inhibitors of cathepsins B and K. Structural background to increased specificity for cathepsin B, Journal of Peptide Research, vol.66, issue.1, pp.1-11, 2005.

M. D. Bailey, Novel Azapeptide Inhibitors of Hepatitis C Virus Serine Protease, Journal of Medicinal Chemistry, vol.47, pp.3788-3799, 2004.
URL : https://hal.archives-ouvertes.fr/hal-02118644

D. Boeglin, Aza-scanning of the Potent Melanocortin Receptor Agonist Ac-His-d-Phe-Arg-Trp-NH2, Chemical Biology & Drug Design, vol.67, pp.275-283, 2006.

. Özlem-do?an-ekici, Design, Synthesis, and Evaluation of Aza-Peptide Michael Acceptors as Selective and Potent Inhibitors of Caspases-2, Journal of Medicinal Chemistry, vol.49, issue.3, pp.5728-5749, 2006.

K. E. and J. , Design, Synthesis, and Evaluation of AzaPeptide Epoxides as Selective and Potent Inhibitors of Caspases-1,-3,-6, and-8, Journal of Medicinal Chemistry, vol.47, issue.6, pp.1553-1574, 2004.

V. Shridhar and . Andurkar, Synthesis and Structural Studies of Aza Analogues of Functionalized Amino Acids: New Anticonvulsant Agents, Journal of Medicinal Chemistry, vol.44, issue.9, pp.1475-1478, 2001.

R. D. Hill and J. C. Vederas, Azodicarboxamides: A New Class of Cysteine Proteinase Inhibitor for Hepatitis A Virus and Human Rhinovirus 3C Enzymes, The Journal of Organic Chemistry, vol.64, pp.9538-9546, 1999.

C. Proulx, Azapeptides and their therapeutic potential, Future Medicinal Chemistry, vol.3, issue.9, pp.1139-1164, 2011.

, Synthetic methodology for alkyl substituted hydrazines, Chemical Society Reviews, vol.30, pp.205-213, 2001.

A. Zega, Azapeptides as Pharmacological Agents, Current Medicinal Chemistry, vol.12, pp.589-597, 2005.

D. Boeglin and W. D. Lubell, Aza-Amino Acid Scanning of Secondary Structure Suited for Solid-Phase Peptide Synthesis with Fmoc Chemistry and Aza-Amino Acids with Heteroatomic Side Chains, Journal of Combinatorial Chemistry, vol.7, issue.6, pp.864-878, 2005.

D. Sabatino, Exploring Side-Chain Diversity by Submonomer Solid-Phase Aza-Peptide Synthesis, Organic Letters, vol.11, pp.3650-3653, 2009.

O. Tsubrik and U. Mäeorg, Combination of tert-Butoxycarbonyl and Triphenylphosphonium Protecting Groups in the Synthesis of Substituted Hydrazines, Organic Letters, vol.3, pp.2297-2299, 2001.

T. Lebleu, Selective monomethylation of primary amines with simple electrophiles, Chemical Communications, vol.50, pp.1836-1838, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00996920

W. P. Malachowski, The Synthesis of Azapeptidomimetic beta-Lactam Molecules as Potential Protease Inhibitors, The Journal of Organic Chemistry, vol.67, pp.8962-8969, 2002.

L. Dufau, Carbonylhydrazide-Based Molecular Tongs Inhibit Wild-Type and Mutated HIV-1 Protease Dimerization, Journal of Medicinal Chemistry, vol.55, pp.6762-6775, 2012.
DOI : 10.1021/jm300181j

URL : https://hal.archives-ouvertes.fr/hal-01544073

F. Ramondo and L. Bencivenni, Molecular conformation of isolated and hydrogen bonded N,N-diformohydrazide: an ab initio study, Journal of the Chemical Society, vol.2, issue.9, pp.1797-1804, 1995.

H. Charles, R. E. Reynolds, and . Hormann, Theoretical Study of the Structure and Rotational Flexibility of Diacylhydrazines: Implications for the Structure of Nonsteroidal Ecdysone Agonists and Azapeptides, vol.118, pp.9395-9401, 1996.

H. Lee, The beta-turn preferential solution conformation of a tetrapeptide containing an azaamino acid residue, Journal of Molecular Structure, vol.569, issue.1, pp.43-54, 2001.

H. Lee, NBO approach to evaluate origin of rotational barrier of diformylhydrazine, Journal of Molecular Structure: THEOCHEM, vol.631, issue.1, pp.101-110, 2003.

S. Vyacheslav, T. K. Bryantsev, B. P. Firman, and . Hay, Conformational Analysis and Rotational Barriers of Alkyl-and Phenyl-Substituted Urea Derivatives, The Journal of Physical Chemistry A, vol.109, issue.5, pp.832-842, 2005.

V. Semetey, Unexpected Stability of the Urea cis?trans Isomer in Urea-Containing Model Pseudopeptides, Organic Letters, vol.3, pp.3843-3846, 2001.

H. J. Lee, Role of azaamino acid residue in beta-turn formation and stability in designed peptide, The Journal of Peptide Research: Official Journal of the American Peptide Society, vol.56, issue.1, pp.35-46, 2000.

H. Ho-jin-lee, K. Park, and . Lee, The beta-turn scaffold of tripeptide containing an azaphenylalanine residue, Biophysical Chemistry, vol.125, pp.117-126, 2007.

C. Abbas, Original and efficient synthesis of 2:1-[alpha/aza]-oligomer precursors, Tetrahedron Letters, vol.50, pp.4158-4160, 2009.

Z. Zhou, Synthesis and Structural Characterization of 2:1 [alpha/Aza]-oligomers, European Journal of Organic Chemistry, vol.34, pp.7643-7650, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01397006

H. Lee, A Theoretical Study of Conformational Properties of N-Methyl Azapeptide Derivatives, Journal of the American Chemical Society, vol.124, pp.11881-11893, 2002.

A. Philipp, G. Ottersbach, M. Schnakenburg, and . Gütschow, Induction of chirality: experimental evidence of atropisomerism in azapeptides, Chemical Communications, vol.48, pp.5772-5774, 2012.

A. Philipp, G. Ottersbach, M. Schnakenburg, and . Gütschow, Atropisomerism in azadipeptides: evaluation of N1-methylation and thioamide introduction, Tetrahedron Letters, vol.56, pp.4889-4891, 2015.

F. André, Aza-peptides. II. X-ray structures of aza-alanine and aza-asparagine-containing peptides, The Journal of Peptide Research: Official Journal of the American Peptide Society, vol.49, issue.6, pp.556-562, 1997.

F. André, Aza-peptides. III. Experimental structural analysis of aza-alanine and aza-asparagine-containing peptides, The Journal of Peptide Research: Official Journal of the American Peptide Society, vol.50, pp.372-381, 1997.

A. Lecoq, Crystal state conformation of three azapeptides containing the Azaproline residue, a beta-turn regulator, Biopolymers, vol.33, issue.7, pp.1051-1059, 1993.

M. Marraud and A. Aubry, Crystal structures of peptides and modified peptides, Biopolymers, vol.40, pp.45-83, 1996.

Z. Benatalah, Evidence for a beta-turn in an azadipeptide sequence. Synthesis and crystal structure of ButCO-Pro-AzaAla-NHPri, International Journal of Peptide and Protein Research, vol.38, issue.6, pp.603-605, 1991.

J. Gante, Synthesis and properties of the first all-aza analogue of a biologically active peptide, Journal of Peptide Science, vol.1, issue.3, pp.201-206, 1995.

Y. Zhang, R. M. Malamakal, and D. M. Chenoweth, AzaGlycine Induces Collagen Hyperstability, Journal of the American Chemical Society, vol.137, pp.12422-12425, 2015.

J. L. Banks, Integrated Modeling Program, Applied Chemical Theory (IMPACT), Journal of Computational Chemistry, vol.26, pp.1752-1780, 2005.

W. and C. Still, Semianalytical treatment of solvation for molecular mechanics and dynamics, Journal of the American Chemical Society, vol.112, pp.6127-6129, 1990.

G. Chang, W. C. Guida, and W. C. Still, An internalcoordinate Monte Carlo method for searching conformational space, Journal of the American Chemical Society, vol.111, pp.4379-4386, 1989.

L. A. Kelley, S. P. Gardner, and M. J. Sutcliffe, An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies, Protein Engineering, vol.9, issue.11, pp.1063-1065, 1996.

W. Kohn and L. J. Sham, Self-Consistent Equations Including Exchange and Correlation Effects, Physical Review, vol.140, pp.1133-1138, 1965.

P. Hohenberg and W. Kohn, Inhomogeneous Electron Gas, Physical Review, vol.136, issue.3, pp.864-871, 1964.

A. D. Becke, Density-functional thermochemistry. III. The role of exact exchange, The Journal of Chemical Physics, vol.98, issue.7, pp.5648-5652, 1993.

C. Lee, W. Yang, and R. G. Parr, Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density, Physical Review B, vol.37, issue.2, pp.785-789, 1988.

W. J. Hehre, Ab Initio Molecular Orbital Theory, vol.576, 1986.

M. J. Frisch, Gaussian 09, Revision A.02, 2009.

S. Miertu?, E. Scrocco, and J. Tomasi, Electrostatic interaction of a solute with a continuum. A direct utilizaion of AB initio molecular potentials for the prevision of solvent effects, Chemical Physics, vol.55, issue.1, pp.117-129, 1981.